Electrophysiology

The cardiac subspecialty of electrophysiology (EP) diagnoses and treats arrhythmias. This includes use of pacemakers to treat bradycardia, implantable cardioverter defibrillators (ICD) for tachycardia, heart failure and patients at risk of sudden cardiac arrest, and cardiac ablation treatments to treat heart rhythm disorders.

Johnson & Johnson MedTech launches new 2D ICE catheter
The company says the new device was designed to improve image quality, provide additional maneuverability and simplify ablation workflows for electrophysiologists.
Johnson & Johnson MedTech ordered to pay $147M for antitrust violations
The company told Cardiovascular Business it respectfully disagrees with the jury's decision and is evaluating all possible legal options going forward. The Association of Medical Device Reprocessors, meanwhile, celebrated the news.
Cardiologists are first in world to use new cooling device to terminate AFib during surgery
Patients often develop AFib during cardiac surgery, leading to longer hospital stays, additional healthcare costs and a higher risk of mortality. Cooling the oblique sinus of the patient's heart as soon as AFib starts to develop may represent a new way to stop the problem in its tracks.
World’s first leadless LBBAP procedures linked to ‘promising’ outcomes
Cardiologists are turning to leadless pacemakers more and more for cardiac pacing, but those devices have not previously been able to perform LBBAP. This new analysis includes new data on the world’s very first leadless LBBAP procedures.
AI predicts LBBB risk in TAVR patients prior to treatment
The authors tested out a variety of machine learning techniques, including large language models and more traditional algorithms. They focused on data that can be gathered prior to treatment, ensuring cardiologists know as much as possible before the procedure.

Christine Albert, MD, MPH, cardiology chair for the Smidt Heart Institute at Cedars-Sinai Medical Center

Rethinking arrhythmias: Women may face a higher AFib risk than men

New research, published in JAMA Cardiology, challenges the common belief that AFib is more likely to develop among men than women. The key problem, it seems, is that prior research teams did not understand the significance of certain risk factors.

Medtronic EV ICD clinical trial safety endpoints ESC Congress 2022

Medtronic’s first-of-its-kind ICD meets safety endpoints in global clinical trial

The promising results were presented at ESC Congress 2022 and published in the New England Journal of Medicine. Medtronic's new-look device is not yet approved for sale or distribution.

Very low doses of edoxaban are safe and effective for frail, elderly AFib patients

Elderly patients are often not eligible for oral anticoagulant therapy due to the risk of bleeding events or other adverse outcomes. A very low dose of edoxaban, however, appears to be a safe treatment option, even for especially frail patients.

Reducing CIED Infections and the Cost of Care: Lessons from Cleveland Clinic

Sponsored by Medtronic

Thinking has changed: Cardiac implantable electronic device (CIED) infections are a bigger deal than we thought.

FDA announces recall of nearly 88,000 implantable cardiac devices due to risk of serious injury or death

The recall is related to short circuit protection (SCP) alerts that were causing the devices to send reduced-energy electric shocks. There have been 27 customer complaints about the issue so far.

CathVision’s ECGenius EP Recording System, a new solution designed to capture high-fidelity, low-noise electrocardiogram (ECG) recordings for the diagnosis and treatment of arrhythmias such as atrial fibrillation (AFib).

Heart rhythm specialists raise $7.2M to fund advances for FDA-cleared ECG system

The new funding all came from existing investors. “Reinvesting in the company demonstrates confidence in our innovation," CathVision's CEO said about the news.

cardiologist patient heart compensation starting salary 2022 interventional cardiologist

Atrial cardiomyopathy tied to a higher risk of dementia, even when patients show no signs of AFib or stroke

Researchers examined decades of data from more than 5,000 patients, sharing their findings in the Journal of the American Heart Association.

AFib screening using wearable devices found to be cost-effective for patients as young as 50

While current guidelines endorse screening for people aged 65 and above, a massive simulation published in JAMA Health Forum suggests that cost-effectiveness may extend to even younger age groups.

Electrophysiology

Johnson & Johnson MedTech launches new 2D ICE catheter

Johnson & Johnson MedTech ordered to pay $147M for antitrust violations

Cardiologists are first in world to use new cooling device to terminate AFib during surgery

World’s first leadless LBBAP procedures linked to ‘promising’ outcomes

AI predicts LBBB risk in TAVR patients prior to treatment